430 related articles for article (PubMed ID: 14501352)
21. [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
Helf D; Schneiderbanger D; Markus CK; Johannsen S; Schuster F
Anaesthesist; 2018 Apr; 67(4):275-279. PubMed ID: 29480319
[TBL] [Abstract][Full Text] [Related]
22. [Malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
[TBL] [Abstract][Full Text] [Related]
23. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
24. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
Brandom BW; Larach MG; Chen MS; Young MC
Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
[TBL] [Abstract][Full Text] [Related]
25. An update on the malignant hyperthermia syndrome.
Rosenberg H; Fletcher JE
Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):84-97. PubMed ID: 7710242
[TBL] [Abstract][Full Text] [Related]
26. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
[TBL] [Abstract][Full Text] [Related]
27. [Two pediatric cases of malignant hyperthermia caused by sevoflurane].
Kinouchi K; Okawa M; Fukumitsu K; Tachibana K; Kitamura S; Taniguchi A
Masui; 2001 Nov; 50(11):1232-5. PubMed ID: 11758332
[TBL] [Abstract][Full Text] [Related]
28. Markedly delayed postoperative malignant hyperthermia.
Souliere CR; Weintraub SJ; Kirchner JC
Arch Otolaryngol Head Neck Surg; 1986 May; 112(5):564-6. PubMed ID: 3954899
[TBL] [Abstract][Full Text] [Related]
29. The severity of sevoflurane-induced malignant hyperthermia.
Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
[TBL] [Abstract][Full Text] [Related]
30. Malignant hyperthermia: current perspectives.
Felice-Johnson J; Sudds T; Bennett G
Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
[TBL] [Abstract][Full Text] [Related]
31. Malignant hyperthermia: a review.
Johnson C; Edleman KJ
J Perinatol; 1992 Mar; 12(1):61-71. PubMed ID: 1560293
[TBL] [Abstract][Full Text] [Related]
32. Masseter muscle rigidity and nondepolarizing neuromuscular blocking agents.
Albrecht A; Wedel DJ; Gronert GA
Mayo Clin Proc; 1997 Apr; 72(4):329-32. PubMed ID: 9121179
[TBL] [Abstract][Full Text] [Related]
33. [Malignant hyperthermia].
Metterlein T; Schuster F; Graf BM; Anetseder M
Anaesthesist; 2014 Dec; 63(12):908-18. PubMed ID: 25384957
[TBL] [Abstract][Full Text] [Related]
34. Malignant hyperthermia: a review.
Rosenberg H; Pollock N; Schiemann A; Bulger T; Stowell K
Orphanet J Rare Dis; 2015 Aug; 10():93. PubMed ID: 26238698
[TBL] [Abstract][Full Text] [Related]
35. A case report of malignant hyperthermia in a dental clinic operating room.
Fukami MC; Ganzberg SI
Anesth Prog; 2005; 52(1):24-8. PubMed ID: 15859446
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
Schleelein LE; Litman RS
Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
[TBL] [Abstract][Full Text] [Related]
37. [Malignant hyperthermia].
Urwyler A; Hartung E
Anaesthesist; 1994 Aug; 43(8):557-69. PubMed ID: 7978181
[TBL] [Abstract][Full Text] [Related]
38. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
[TBL] [Abstract][Full Text] [Related]
39. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Schuster F; Johannsen S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
